Profil bibliographique

Laure Farnault

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

94Publications signalées

1208Citations signalées

2Affiliations récentes

Institutions déclarées

Aix-Marseille Université Hôpital de la Conception

Domaines associés

Acute Myeloid Leukemia ResearchAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia ResearchHematopoietic Stem Cell Transplantation

Publications récentes

2026 articleOpenAlex

Real-world patterns of treatment intensity and prognostic model performance in older acute myeloid leukemia: insights from the French ALFA-PPP Cohort

Lin‐Pierre Zhao, Céline Berthon, Laurène Fenwarth, Stéphane de Botton et autres

0 citationsLeukemia

2026 articleOpenAlex

Blinatumomab consolidation for high-risk Ph− B-cell acute lymphoblastic leukemia: the GRAALL-2014/B-QUEST study

Nicolas Boissel, F. Huguet, T. Leguay, Mathilde Hunault et autres

5 citationsBlood

2026 articleOpenAlex

Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement

Benoît Ducourneau, Arnaud Pagès, Stéphanie Struski, Matthieu Décamp et autres

0 citationsLeukemia

Accès ouvert 2026 articleOpenAlex

Sustained remission after discontinuation of ALK inhibition in ALK-positive histiocytosis

Paul G. Kemps, Jennifer Picarsic, Sébastien Héritier, Jean Donadieu et autres

1 citationBlood Cancer Journal

2026 conference-abstractOpenAlex

Abstract 1834: A mathematical model for fitting adjusting azacytidine in AML or SMD patients.

Quentin Gerbault, Loïc Osanno, Joseph Ciccolini, Laure Farnault et autres

0 citationsCancer Research

Accès ouvert 2025 articleOpenAlex

Predicting the toxicity-efficacy ratio of venetoclax in real-world patients

Loïc Osanno, Lucy Brocque, Laurent Bourguignon, C. Delpech et autres

0 citationsAnnals of Hematology

2025 conference-abstractOpenAlex

Blinatumomab consolidation in high-risk Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia in adults: Final report of the graall-2014/b-QUEST study.

Nicolas Boissel, Françoise Huguet, Thibaut Leguay, Hunault-Berger Mathilde et autres

0 citationsBlood

Accès ouvert 2025 conference-abstractOpenAlex

Treatments and outcomes of adult patients with TP53-mutated acute myeloid leukemia (AML) in the real-life –Report of the prospective french observational ALFA-PPP study.

Jean-Baptiste Micol, Raphaël Itzykson, Laure Farnault, Thomas Cluzeau et autres

1 citationBlood

Accès ouvert 2025 conference-abstractOpenAlex

Real life treatments and outcomes of older patients aged more than 60 years with FLT3-mutated acute myeloid leukemia: Report from the multicentric french observational ALFA-PPP study

Ramy Rahmé, Emmanuel Raffoux, Lionel Adès, Stéphane de Botton et autres

0 citationsBlood

Accès ouvert 2025 conference-abstractOpenAlex

Real-world patterns of treatment intensity and prognostic model performance in older AML: Insights from the french ALFA-PPP cohort

Lin-Pierre Zhao, Céline Berthon, L. Fenwarth, Stéphane de Botton et autres

0 citationsBlood

2025 conference-abstractOpenAlex

Real-life CD34+CD38- leukemic stem cell (LSC) flow quantification in adult AML at diagnosis independently predicts survival of intensively but not AZA-VEN treated patients: A study of prospective observational ALFA-PPP acute leukemia french association

Adriana Pleșa, Alexandra Coelho, Stéphanie Mathis, Véronique Saada et autres

1 citationBlood

Accès ouvert 2025 articleOpenAlex

Update on long-term outcomes of a cohort of patients with -positive acute lymphoblastic leukemia treated with blinatumomab and stem cell transplantation

Aida Zečkanović, Brice Mouttet, Luciana Vinti, Philip Ancliff et autres

0 citationsZurich Open Repository and Archive (University of Zurich)

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.